Peptoids and Methods for Treating Alzheimer's Disease

Description:

Technology # 12-14 (Also refer to 15-18)

 

 

A Method of Treating Alzheimer's Disease

Alzheimer’s disease is a devastating disease that progressively robs the memory and the mental abilities of the patient. There currently is no cure for Alzheimer’s, or even a treatment to slow the progression of the disease. Alzheimer’s disease affects more than 26.6 million people worldwide and is predicted to affect 1 in 85 people globally by 2050. Although there is no conclusive known cause of the disease, the presence of beta-amyloid plaques in the brain is associated with the disease and its symptoms. New peptoids have been created that prevent the aggregation of the beta amyloids, and may break up existing amyloids.

 

Application(s):

Therapeutics for protein aggregation diseases, including Alzheimer's Disease.

 

Advantage(s):

Currently there are no known therapies available that prevent the progression of Alzheimer's Disease.

 

Technology:

New peptoids have been created that prevent the aggregation of the beta amyloids, and may break up existing amyloids. These peptoids are currently being tested and research is on-going. The new peptoids may be developed into drugs which could be administered to Alzheimer’s patients to prevent further damage to their brains, and possibly even to reverse the effects of the disease.

 

__________________________________________________

The invention is patent pending and is available for license. 

For interested parties seeking further information, feel free to contact:

 

Mark Allen Lanoue

Technology Manager / Tech Ventures

University of Arkansas

(479) 575-7243

malanoue@uark.edu

 

 

Patent Information:
For Information, Contact:
Mark Lanoue
Technology Manager
University of Arkansas
479-575-7243
malanoue@uark.edu
Inventors:
Shannon Servoss
Melissa Moss
Keywords:
© 2020. All Rights Reserved. Powered by Inteum